Abstract |
This study was designed to assess whether histological and biological factors of breast cancer can predict chemoresponse to specific agents. Adenosine triphosphate-based chemotherapy response assay ( ATP-CRA) was employed to retrieve chemoresponse to 5-fluorouracil (5-FU), doxetaxel, doxorubicin, epirubicin, and paclitaxel in 49 patients. Tumors with high histologic and nuclear grade have higher response rate to doxorubicin (P<0.05) and palitaxel (P<0.05). Estrogen receptor (ER)-negative tumors respond well to doxorubicin (P=0.038), and progesterone receptor (PR)-negative tumors to 5-FU (P=0.039), doxetaxel (P=0.038), doxorubicin (P=0.000), epirubicin (P=0.010), and paclitaxel (P=0.003). Among the breast cancer subtypes determined by ER, PR, and HER-2 immunohistochemical stains, the HER-2+/ER- subtype has a higher response rate to doxorubicin (P=0.008). This in vitro result suggests that the combination of histologic and nuclear grade, hormone receptor, and HER-2 status can be a predictive factor of response to specific chemotherapy agents. Further in vivo study should be followed for clinical trials.
|
Authors | Ja Seung Koo, Woohee Jung, Eunah Shin, Hy-de Lee, Joon Jeong, Kun-Hong Kim, Hyeongjae Jeong, Soon Won Hong |
Journal | Journal of Korean medical science
(J Korean Med Sci)
Vol. 24
Issue 6
Pg. 1150-7
(Dec 2009)
ISSN: 1598-6357 [Electronic] Korea (South) |
PMID | 19949674
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Receptors, Estrogen
- Receptors, Progesterone
- Epirubicin
- Doxorubicin
- Adenosine Triphosphate
- ERBB2 protein, human
- Receptor, ErbB-2
- Paclitaxel
- Fluorouracil
|
Topics |
- Adenosine Triphosphate
(metabolism)
- Adult
- Aged
- Antineoplastic Agents
(therapeutic use)
- Breast Neoplasms
(classification, drug therapy, pathology)
- Doxorubicin
(therapeutic use)
- Drug Screening Assays, Antitumor
(methods)
- Epirubicin
(therapeutic use)
- Female
- Fluorouracil
(therapeutic use)
- Humans
- Middle Aged
- Paclitaxel
(therapeutic use)
- Receptor, ErbB-2
(genetics, metabolism)
- Receptors, Estrogen
(genetics, metabolism)
- Receptors, Progesterone
(genetics, metabolism)
|